C-reactive protein and target organ damage in untreated patients with primary hypertension

Journal of the American Society of Hypertension

Volumn 1, Issue 6, 2007, Pages 407-413

  Ratto, Elena ^a   Leoncini, Giovanna ^a   Viazzi, Francesca ^a   Falqui, Valeria ^a   Parodi, Angelica ^a   Conti, Novella ^a   Tomolillo, Cinzia ^a   Deferrari, Giacomo ^a   Pontremoli, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

carotid artery; left ventricular hypertrophy; microalbuminuria; Microinflammation

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIPLE REGRESSION; NEPHELOMETRY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 36549061002     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2007.09.003     Document Type: Article

References (32)

1. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
2. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
3. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
4. Cook N.R., Buring J.E., and Ridker P.M. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 145 (2006) 21-29
5. Koenig W., Lowel H., Baumert J., and Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in Southern Germany. Circulation 109 (2004) 1349-1353
6. Devereux R.B., and Alderman M.H. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation 88 (1993) 1444-1455
7. Pontremoli R., Sofia A., Ravera M., Nicolella C., Viazzi F., Tirotta A., et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications. Hypertension 30 (1997) 1135-1143
8. Tracy R.P., Psaty B.M., Macy E., Bovill E.G., Cushman M., Cornell E.S., et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 17 (1997) 2167-2176
9. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
10. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
11. de Simone G., Devereux R.B., Daniels S.R., Koren M.J., Meyer R.A., and Laragh J.H. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25 (1995) 1056-1062
12. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). [Erratum in: 2007;25:1749]. J Hypertens 25 (2007) 1105-1187
13. Wendelhag I., Wiklund O., and Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 13 (1993) 1404-1411
14. Leoncini G., Ratto E., Viazzi F., Vaccaro V., Parodi A., Falqui V., et al. Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension. Hypertension 48 (2006) 397-403
15. Schillaci G., and Pirro M. C-reactive protein in hypertension: clinical significance and predictive value. Nutr Metab Cardiovasc Dis 16 (2006) 500-508
16. King D.E., Egan B.M., Mainous A.G., and Geesey M.E. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens 6 (2004) 562-568
17. Chrysohoou C., Pitsavos C., Panagiotakos D.B., Skoumas J., and Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease: the ATTICA Study. Am J Hypertens 17 (2004) 568-573
18. Sesso H.D., Buring J.E., Rifai N., Blake G.J., Gaziano J.M., and Ridker P.M. C-reactive protein and the risk of developing hypertension. JAMA 290 (2003) 2945-2951
19. Schillaci G., Pirro M., Gemelli F., Pasqualini L., Vaudo G., Marchesi S., et al. Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens 21 (2003) 1841-1846
20. Chobanian A.V., and Alexander R.W. Exacerbation of atherosclerosis by hypertension. Potential mechanisms and clinical implications. Arch Intern Med 156 (1996) 1952-1956
21. Intengan H.D., and Schiffrin E.L. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38 (2001) 581-587
22. Blake G.J., Rifai N., Buring J.E., and Ridker P.M. Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 108 (2003) 2993-2999
23. Olsen M.H., Christensen M.K., Hansen T.W., Gustafsson F., Rasmussen S., Wachtell K., et al. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors. J Hypertens 24 (2006) 655-661
24. Palmieri V., Tracy R.P., Roman M.J., Liu J.E., Best L.G., Bella J.N., et al. Strong Heart Study. Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study. Diabetes Care 26 (2003) 2764-2769
25. Tsioufis C., Stougiannos P., Kakkavas A., Toutouza M., Mariolis A., Vlasseros I., et al. Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension. Am J Cardiol 96 (2005) 252-256
26. Tsioufis C., Dimitriadis K., Chatzis D., Vasiliadou C., Tousoulis D., Papademetriou V., et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol 96 (2005) 946-951
27. Tsioufis C., Dimitriadis K., Taxiarchou E., Vasiliadou C., Chartzoulakis G., Tousoulis D., et al. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects. Am J Hypertens 19 (2006) 462-466
28. Hashimoto H., Kitagawa K., Hougaku H., Etani H., and Hori M. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke 35 (2004) 1625-1630
29. Verma S., Devaraj S., and Jialal I. Is C-reactive protein an innocent bystander or proatherogenic culprit?. C-reactive protein promotes atherothrombosis. Circulation 113 (2006) 2135-2150
30. Mahmud A., and Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 46 (2005) 1118-1122
31. Miller M., Zhan M., and Havas S. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Arch Intern Med 165 (2005) 2063-2068
32. Albert M.A., Glynn R.J., and Ridker P.M. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation 108 (2003) 161-165